QT Imaging Holdings, Inc. (QTI) – What Are Investment Firms Thinking About This Stock?

Shares of QT Imaging Holdings, Inc. (NASDAQ:QTI) have been assigned an average rating of “Hold” from the five ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $8.50.

A number of brokerages recently weighed in on QTI. Craig Hallum started coverage on shares of QT Imaging in a report on Monday, October 5th. They issued a “buy” rating and a $8.00 price objective for the company. D. Boral Capital initiated coverage on QT Imaging in a research note on Friday. They set a “buy” rating and a $9.00 target price on the stock. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of QT Imaging in a research note on Tuesday, October 6th.

QT Imaging Price Performance

NASDAQ:QTI traded down $0.11 during mid-day trading on Friday, hitting $2.25. 41,732 shares of the stock traded hands, compared to its average volume of 40,892. The company has a market cap of $30.98 million, a PE ratio of -1.43 and a beta of 0.02. The company has a quick ratio of 2.06, a current ratio of 3.10 and a debt-to-equity ratio of 6.81. The business’s 50-day moving average price is $2.67 and its 200 day moving average price is $3.97. QT Imaging has a 12-month low of $2.25 and a 12-month high of $8.50.

QT Imaging (NASDAQ:QTI) last issued its earnings results on Wednesday, August 12th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.53). QT Imaging had a negative return on equity of 1,202.69% and a negative net margin of 77.25%. The business had revenue of $7.44 million during the quarter, compared to analysts’ expectations of $7.60 million. On average, analysts expect that QT Imaging will post -1.11 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of QTI. Stonepine Capital Management LLC purchased a new stake in QT Imaging in the second quarter valued at approximately $407,000. Polar Asset Management Partners Inc. acquired a new stake in shares of QT Imaging in the 2nd quarter worth $210,000. Finally, BlackRock Inc. boosted its position in shares of QT Imaging by 116.5% during the 2nd quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock worth $250,000 after purchasing an additional 33,009 shares in the last quarter. 24.19% of the stock is owned by hedge funds and other institutional investors.

QT Imaging Company Profile

QT Imaging Holdings, Inc develops medical imaging technology designed to support breast cancer screening and diagnostic procedures. The company’s flagship product, QTscan, is a three-dimensional, transmission-based breast imaging system that uses ultrasound technology to produce images without ionizing radiation, breast compression or injectable contrast agents.

QTscan is intended for use by healthcare providers as an imaging tool for evaluating breast tissue, including in patients with dense breasts.